Immix Biopharma
IMMX
#9281
Rank
A$99.18 M
Marketcap
$3.61
Share price
3.21%
Change (1 day)
-64.82%
Change (1 year)

Earnings for Immix Biopharma (IMMX)

Earnings in 2024 (TTM): -A$33.85 Million

According to Immix Biopharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$25.5 Million a decrease over its 2022 earnings that were of -A$13.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immix Biopharma from 2021 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$33.85 Million32.74%
2023 -A$25.5 Million93.61%
2022 -A$13.18 Million-66.03%
2021 -A$38.78 Million